Skip to main content

Own Apple Powerbeats 2 earphones? Here’s how to claim your share of a $9.75 million settlement

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism, subscribe today.

Owners of Apple’s Beats-branded Powerbeats 2 earphones may be able to get some cash from a proposed $9.75 million legal settlement.

Customers who bought a pair of the earphones before Aug. 7, 2020 qualify. Only people who purchased them from an official retailer—that excludes eBay-style secondhand resellers—are eligible.

To receive an award, people must file a claim form online here or submit a downloadable form through the mail.

Some customers may have already received a personalized notice of the settlement, via mail or email, alerting them of their options. The notices should include a “claim identification number” and a “confirmation code,” which can be entered here.

The deadline to file a claim—online or postmarked—is Nov. 20, 2020.

Head-phoniness

The class action lawsuit, filed in 2017, accuses Apple of falsely advertising a “shoddy” product. The plaintiffs allege that the headphones “contain a design defect that causes them to stop retaining a charge.” Apple is also accused of deceiving consumers about the headphones’ durability and sweat-resistance. And further, the company is said to have replaced any earphones returned through its one-year warranty program with products that contained the same flaws.

“Apple continues to promote and market its faulty Powerbeats, and continues to profit handsomely from their sale,” the lawsuit said. “In so doing, Apple has defrauded the public and cheated its consumers.”

As part of the proposed settlement, Apple has denied any wrongdoing. The two parties agreed to the settlement to avoid dragging out the litigation.

The presiding court in California’s Santa Clara County gave preliminary approval to the deal. The court must deliver its final approval on Jan. 21, 2021, at which claimants can air any objections.

Beats to the punch

To how much money will everyone be entitled?

As is the case with most class action lawsuits, a large portion is set aside for the lawyers. Legal fees and administrative costs are expected to consume, roughly, $3.7 million. The remaining amount will be split between applicants, so the ultimate payout will depend on how many people apply.

The maximum payout for any individual is $189.

The proposal uses a point-based system to earmark funds for claimants. The system awards more points to people who supply more evidence in support of their claim, such as proofs of purchase and records of warranty repairs or replacements. (For a detailed description, see pages four and five of the proposed settlement here.)

Assuming 75,000 people submit a claim and they show, on average, one proof of purchase, one record of warranty repair or replacement, or both, each will receive about $80 apiece. If 150,000 people apply under the same conditions, each will receive about $40.

Any leftover funds are set to go to the Consumer Federation of America, a nonprofit consumer advocacy group.

Powerbeats 2 cost $200 when they debuted in 2015.

A battery of lawsuits

This isn’t the only class action lawsuit Apple is settling.

As part of another case, Apple fessed up to intentionally slowing down people’s iPhones, including many models in the iPhone 6 and 7 generations. The phones’ batteries were incapable of keeping up with the demands of the company’s frequent software updates.

People can file a claim for $25 as part of the proposed settlement here. The deadline to submit is Oct. 6, 2020.

Anyone who wishes to sue Apple independently of the class action lawsuit should not submit a claim, though that route also forfeits one’s claim to the payouts described above.

More must-read tech coverage from Fortune:



from Fortune https://ift.tt/2ELwhsy

Comments

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be